1. Home
  2. SGHT vs NKLR Comparison

SGHT vs NKLR Comparison

Compare SGHT & NKLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$6.10

Market Cap

395.5M

Sector

Health Care

ML Signal

HOLD

NKLR

Terra Innovatum Global N.V. Ordinary shares

N/A

Current Price

$4.30

Market Cap

426.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SGHT
NKLR
Founded
2011
2018
Country
United States
Italy
Employees
N/A
N/A
Industry
Medical Specialities
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
395.5M
426.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SGHT
NKLR
Price
$6.10
$4.30
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$8.23
$17.50
AVG Volume (30 Days)
280.7K
789.6K
Earning Date
03-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,052,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$3.73
52 Week High
$9.24
$21.91

Technical Indicators

Market Signals
Indicator
SGHT
NKLR
Relative Strength Index (RSI) 36.73 34.56
Support Level $5.95 $5.40
Resistance Level $6.59 $4.94
Average True Range (ATR) 0.34 0.64
MACD 0.02 -0.20
Stochastic Oscillator 17.44 3.99

Price Performance

Historical Comparison
SGHT
NKLR

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About NKLR Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor SOLO. SOLO is compact yet extremely powerful with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.

Share on Social Networks: